Alpha Teknova, Inc. (TKNO) Dividend History

Alpha Teknova, Inc. (TKNO) is a biotechnology company that develops and supplies essential reagents and materials for the healthcare and life sciences industries. Focused on providing high-quality products for diagnostics, pharmaceutical research, and other laboratory applications, Teknova supports scientific discovery and clinical testing through innovation and reliable supply chains.

2451 Bert Drive, Hollister, CA, 95023
Phone: (831) 637-1100
Website: https://www.teknova.com

Dividend History

Alpha Teknova, Inc. currently does not pay dividends

Company News

  • Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

    Teknova and Pluristyx are collaborating to produce and commercialize Pluristyx's PluriFreeze cryopreservation system, which is designed to simplify the scale-up process for companies working to bring allogeneic cell therapies to market.

    GlobeNewswire Inc.
  • Telegraph Hill Partners buys $15m of Alpha Teknova shares at $1.24 each - Investing.com

    Telegraph Hill Partners, a major shareholder in Alpha Teknova, Inc., has increased its stake in the company through a private placement, purchasing shares worth approximately $15 million at $1.24 per share. This transaction reflects a positive outlook from Telegraph Hill Partners on Alpha Teknova's future prospects.

    Investing.com
  • After Plunging -24.59% in 4 Weeks, Here's Why the Trend Might Reverse for Alpha Teknova (TKNO)

    Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

    Zacks Investment Research
  • Why Gritstone bio Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

    Gainers Inpixon (NASDAQ: INPX) shares rose 44.6% to $0.2023 in pre-market trading after gaining around 10% on Wednesday. Gritstone bio, Inc. (NASDAQ: GRTS) shares rose 37% to $1.63 in pre-market trading after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a next-generation vaccine candidate for COVID-19 valued at up to $433 million. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares gained 23% to $0.7240 in pre-market trading after falling 15% on Wednesday. TransCode Therapeutics recently priced its $8 million public offering of 15.7 million shares at $0.51/share. Actelis Networks, Inc. (NASDAQ: ASNS) shares surged 22.4% to $1.42 in pre-market trading after the company announced it achieved Third Party Validation for FIPS cyber protection standard required by government agencies. PARTS iD, Inc. (NYSE: ID) shares rose 21.9% to $0.1980 in pre-market trading after dipping around 38% on Wednesday. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 18.1% to $4.24 in pre-market trading. Connexa Sports Technologies recently announced that it received a letter from the Nasdaq regarding the late filing of its quarterly ...

    Benzinga
    Featured Companies: ASNS ASST ASTI ICU LULU PTON RNAZ SYBX XWEL
Page data last updated 07/25/2025 01:08:43 UTC